广发纳斯达克生物科技人民币(001092)

动态评分: 5.30分

投资组合

报告日期 名称 比例
2024-06-30 4D Molecular Therapeutics Inc 0.1%
2024-06-30 Genmab A/S ADR 0.1%
2024-06-30 Innoviva Inc 0.1%
2024-06-30 Prothena Corp plc 0.1%
2024-06-30 Maravai LifeSciences Holdings Inc-A 0.09%
2024-06-30 Tango Therapeutics Inc 0.09%
2024-06-30 再鼎医药 0.08%
2024-06-30 AbCellera Biologics Inc 0.08%
2024-06-30 Aurinia Pharmaceuticals Inc 0.08%
2024-06-30 Relay Therapeutics Inc 0.08%
2024-06-30 Cogent Biosciences Inc 0.08%
2024-06-30 ARS Pharmaceuticals Inc 0.08%
2024-06-30 基立福 0.07%
2024-06-30 89bio Inc 0.07%
2024-06-30 Autolus Therapeutics plc ADR 0.07%
2024-06-30 Harrow Health Inc 0.07%
2024-06-30 Kiniksa Pharmaceuticals International plc-A 0.07%
2024-06-30 CureVac NV 0.07%
2024-06-30 Bicycle Therapeutics Ltd ADR 0.07%
2024-06-30 Arbutus Biopharma Corp 0.06%

投资模拟

公告&资料